promoter hypermethylation (Morton et al, 1993; Vermeulen et al, 1996; Crundwell et al, 1997) .
Previous studies indicate that E-cadherin expression correlates inversely with tumour grade and stage in various cancers (Breen et al, 1995; Rimm et al, 1995; van der Wurff et al, 1997) , including prostate cancer (Umbas et al, 1994; Crundwell et al, 1997; Murant et al, 1997; Paul et al, 1997; Richmond et al, 1997) , and it seems to have prognostic value (Umbas et al, 1994; Richmond et al, 1997) . The significance of α-catenin is not completely understood in prostate cancer progression (Crundwell et al, 1997; Murant et al, 1997; Paul et al, 1997; Richmond et al, 1997; Umbas et al, 1997) . Initial studies (Crundwell et al, 1997; Richmond et al, 1997) based on small number of prostate cancer cases, reveal that up to 40% of the tumours may show abnormal α-catenin expression. In addition, this down-regulation correlates to disease progression (Crundwell et al, 1997; Richmond et al, 1997; Umbas et al, 1997) . Prompted by the above mentioned observations (Crundwell et al, 1997; Shimazui et al, 1997; Umbas et al, 1997; Zsciesche et al, 1997) we (a) analysed the expression of α-catenin in unselected large series of prostate cancer and (b) related the results to other known prognostic factors and patient survival.
MATERIALS AND METHODS

Patients
The current study comprised 215 patients with prostate cancer diagnosed and treated at the Department of Urology, Kuopio α-Catenin expression has prognostic value in local and locally advanced prostate cancer University Hospital, between 1973 and 1992 . The mean observation period was 13 years [standard deviation (s.d.) 3, range 8-21] and the mean age of patients at presentation was 72 years (s.d. 8, range 40-89). The cohort was not entirely consecutive since sufficient tumour specimens for immunohistochemistry were not available in all cases. Tumour-metastasis classification was done according to UICC standards (UICC, 1978) . Radical prostatectomy was rarely done during the study period, which explains why the node (N) classification was not available. The patients were treated by orchiectomy in 100 cases, other endocrine therapy was used in 70 cases, radical prostatectomy or radiation therapy was done in nine cases and careful follow-up only was used in 76 cases. The follow-up reviews were done at 3-month intervals during the first 2 years, and thereafter at 6-month intervals. At the time of diagnosis, 61/215 (28%) cases had distant metastasis. The causes of death were verified from the patient files, autopsy reports and from the files of Finnish Cancer Registry.
Histological methods and flow cytometry
The histological samples were core needle biopsies or TURP specimens fixed in buffered formalin (pH 7.0), embedded in paraffin, sectioned at 5 µm and stained with haematoxylin and eosin. The histological differentiation of tumours was evaluated as described by Gleason (1977) . The perineural growth was categorized into two groups; present or absent. The mitotic figures were identified and calculated from the most actively proliferating area in the section (Vesalainen et al, 1995) . The volume corrected mitotic index method (M/V index) was used, which expresses the number of mitotic figures/square millimetre of tumour tissue in the section (Vesalainen et al, 1995) . The results of flow cytometry have been reported in detail previously (Vesalainen et al, 1994) . DNA index was available in 182/215 (85%) of cases and S phase fraction in 175/215 (81%) of cases.
α-Catenin immunohistochemistry
Five-micrometre-thick sections from the primary tumours were deparaffinized, rehydrated and washed twice for 5 min with phosphate-buffered saline (PBS). For α-catenin analysis, the sections were heated in a microwave oven in 0.005 M HCl (pH = 9.7) for 2 × 5 min.
Endogenous peroxidase activity was blocked with 5% hydrogen peroxide for 5 min, followed with a wash for 2 × 5 min with PBS. The tissue sections were incubated overnight at 4°C with a primary mouse monoclonal anti α-catenin antibody (Transduction Laboratories, Lexington, KY, USA) at a working dilution of 1:100. Sections were washed twice for 5 min with PBS and incubated for 30 min using a biotinylated secondary antigen (Vectastain ABC Elite kit, Vector Laboratories, CA, USA) diluted 1:200 in PBS. Slides were washed twice in PBS for 2 × 5 min and incubated for 40 min in preformed avidin-biotinylated peroxidase complexes (Vectastain ABC Elite kit, Vector Laboratories, CA, USA). Sections were washed twice for 5 min with PBS, developed for 5 min with 0.05% 3,3-diaminobenzidine tetrahydrochloride (DAB) (Sigma, UK), slightly counterstained with haematoxylin, dehydrated, cleared and mounted with DePex (BDH, Limited Poole, UK). In each staining batch, normal epithelium served as a positive control. In negative controls, primary antibody was omitted.
Scoring of immunohistochemistry
The expression of α-catenin in cancer cells was compared with that of normal epithelial cells in the sample. First, the intensity of the staining was scored as follows: negative (0), weak (1) or strong (2). Cancer cells which stained as strong as the normal prostate epithelium were defined as normal expressors (strong intensity). Weak expression was defined as a faint staining clearly weaker than that in normal epithelium. Secondly, the localization of staining signal was categorized into two groups: staining along the cell membranes and cytoplasmic involvement in addition to membranous staining. Finally, the staining signal was graded according to the proportion of positive cancer cells. The fraction of positive cancer cells (%) was primarily analysed in a continuous scale, but for statistical calculations, tumours having over 95% cancer cells positively stained were considered as positive (normal). The others were considered as abnormal. In the scoring process, only well-preserved tumour tissue was evaluated. It became evident that in TURP specimen the chip margins frequently showed no α-catenin signal, probably due to tissue denaturation and coagulation during TURP procedure. To validate the above described scoring principle, a test set of 48 prostatectomy sections were analysed to test the frequency of abnormal α-catenin expression in surgically removed tissues.
Statistical analysis
In the basic statistical calculations, the SPSS-X program package was used in an IBM computer and the statistical tests used are indicated in connection with the results when appropriate. Univariate survival analysis (log-rank analysis) was based on a life-table method with statistics by Gehan (SPSS-X). Multivariate survival analysis (Cox's analysis) used deaths from prostate cancer as events. Multivariate analysis was done in two phases. The first analysis included TM-categories, Gleason score and the α-catenin indices. The second analysis included all the available parameters.
RESULTS
Normal and hyperplastic prostate epithelium in the close vicinity of tumours showed strong positive staining along cell membranes throughout the cell-cell boundaries. The intensity of staining was strong (normal) in 190 (88%) tumours ( Figure 1A ) and weak in 19 (9%) tumours. Six tumours (3%) were completely negative for α-catenin ( Figure 1B) . Staining pattern along cell membranes was observed in 189 (88%) cases and additional cytoplasmic involvement ( Figure 1C ) was present in 20 cases (9%). The staining was regarded abnormal (positive tumour cells less than 95% of the total tumour cell population) in 39 (18%) cases. The test set treated by surgical prostatectomy revealed one α-catenin negative case (2%) and seven cases (15%) with less than 95% of positive cells. These figures correspond to those found in the main series of prostate cancer cases.
Both cytoplasmic involvement (χ 2 = 89, P < 0.001) and weak staining intensity (χ 2 = 59, P < 0.001) were related to abnormal α-catenin expression (positive cells less than 95%). In addition, weak intensity was significantly associated with high grade (P = 0.006) and T3-T4 categories (P = 0.0007), but not with other analysed cellular features. The negative staining, as well as the cytoplasmic localization of α-catenin, were linked with high T classification, high grade, presence of perineural infiltration, DNA aneuploidy, high mitotic index, high S phase fraction and metastasis (Table 1 ). The reduced expression of α-catenin (positive cells less than 95%) was related to several prognostic factors as detailed in Table 2 . In the test set of prostate cancers, all the cases with abnormal α-catenin expression belonged to pT3A-pT3C categories, except one case which was pT4. The Gleason score was over 6 in six of the cases with abnormal α-catenin expression.
In the univariate survival analysis, cytoplasmic signal in addition to membranous staining predicted unfavourable patient outcome (Figure 2 ). The reduced expression was associated with lowered survival probability in the entire series with a borderline significance (Figure 3 ). However, it had no statistically significant prognostic value either in M0 (P = 0.2) or in T1-2 M0 tumours (Figure 4) .
In the multivariate analysis including TM-classification, Gleason score and α-catenin indices, abnormal α-catenin staining had independent prognostic value only in T1-2 M0 tumors (Table 3) . Recurrence-free survival of M0 tumors was independently related to T-category (relative risk (RR) = 1.74, 95% confidence interval (CI) 1.27-2.39, P < 0.001), DNA aneuploidy (RR = 3.41, 95% CI 1.74-6.69, P < 0.001) and the staining intensity of α-catenin (RR = 0.51, 95% CI 0.29-0.89, P = 0.017). If all the analysed features (T-category, presence of metastases, Gleason grade, perineural infiltration, mitotic index, DNA ploidy and S phase fraction) were entered in the model, independent prognostic factors in the entire series were M-category (RR = 3.12, 95% CI 1.78-5.46, P = 0.0002), T-category (RR = 1.75, 95% CI 1.33-2.29, P = 0.0001) and M/V index (RR = 1.02, 95% CI 1.00-1.05, P = 0.041). In M0 tumours, independent predictors were T-category (RR = 1.59, 95% CI 1.12-2.24, P = 0.005) and Gleason score (RR = 3.30, 95% CI 1.43-7.60, P = 0.005). Finally, in clinically local T1-2 M0 tumours, Gleason score (RR = 3.08, 95% CI 1.15-8.21, P = 0.024) and M/V index (RR = 1.06, 95% CI 1.01-1.12, P = 0.009) were independent prognostic factors of survival.
DISCUSSION
Normal and hyperplastic prostatic epithelium revealed normal, strong and uniform staining pattern of α-catenin, whereas in cancer tissue various α-catenin staining signals were frequently detected. The α-catenin expression was abnormal in 18% of the cases in the main series. Consequently, 15% of cases in the test set treated by prostatectomy showed similar reduced α-catenin signal.
In a heterogenous group of prostate cancers, Richmond and co-workers (Richmond et al, 1997) reported up to 41% of the tumours (33/79 cases) showing abnormal α-catenin expression which is a higher figure than ours. Another previous study with local incidentally detected tumours reported that the proportion of abnormal α-catenin expression was over 40% (10/23 cases) (Crundwell et al, 1997) . Both of these studies have utilized TURP specimens for immunohistochemistry but no description is given whether all the tumour tissue was used in the scoring process. According to our experience, it is highly important to exclude the TURP chip margins from evaluation since the tissue damage due to heating seems to abolish α-catenin immunoreactivity. Additional support for this comes from our test set (surgical prostatectomy specimens) which showed a similar frequency distribution of α-catenin as the main series. We believe that this notion seems to validate the adopted scoring principle. Similar results have also been reported by Umbas and co-workers (Umbas et al, 1997) , since they observed aberrant α-catenin expression in 52% of the heterogeneous group of prostate tumours, while in their small radically operated group of tumours only 20% (4/20) of the cases showed abnormal α-catenin expression (Umbas et al, 1997) .
There was a significant relationship between the reduced α-catenin expression and high Gleason score, suggesting more aggressive behaviour and increased potential to spread locally and to distant sites. A similar relationship between high grade and α-catenin abnormalities has been previously reported both in prostate cancer (Richmond et al, 1997) and in other epithelial The survival of patients with a T1-2 M0 tumour categorized according to the expression of α-catenin (P = 0.1, χ 2 = 2.6). Curve A: α-catenin normal, n = 121; Curve B: α-catenin abnormal, n = 14 neoplasms (Rimm et al, 1995; Shimazui et al, 1997; van der Wurff et al, 1997) . α-catenin abnormalities were frequently detected in tumours showing perineural growth which indicates that α-catenin abnormalities also favour invasive growth in vivo. The significant relationship between α-catenin abnormalities and all proliferation indices found in this study is in line with the inter-relationship between Gleason score and α-catenin abnormalities (Richmond et al, 1997) . The presence of metastasis and local spread were related to reduced α-catenin expression. Abnormalities in the staining found in our T1-T2 tumours were rare but the frequency clearly increased in T3-T4 tumours. Similarly, in the test set of tumours treated by prostatectomy, the final histopathological analysis of the prostatectomy specimens (pT) revealed that all the tumours showing down-regulation of α-catenin belonged mostly to pT3A-C categories. These results suggest that tumours with reduced α-catenin expression rapidly progress locally into invasive disease. It is obvious that the metastatic potential of prostate tumours is not dependent on cell adhesion factors alone, and many other factors including the host response are involved (Vesalainen et al, 1994) . In alignment with our notion, the relationship between α-catenin expression and tumour spread has been reported previously in prostate cancer (Richmond et al, 1997) and in tumours of the urinary tract (Shimazui et al, 1996) .
The earlier studies in prostate cancer indicate that α-catenin abnormalities predict unfavourable prognosis (Richmond et al, 1997; Umbas et al, 1997) . In our study, abnormal signal localization as well as down-regulation of α-catenin were related to unfavourable prognosis supporting these previous findings (Richmond et al, 1997; Umbas et al, 1997) .
Since several genetic changes occur simultaneously in prostate cancer (Isaacs, 1995) , only multivariate analysis of prognostic factors can give insight to the impact of individual prognostic factors on patient survival. In the current study abnormal α-catenin expression was an independent prognosticator only in T1-2 M0 group of tumours and when Gleason score, T-classification and different α-catenin indices were included in the analysis. In a subgroup analysis of M0 cases, reduced α-catenin signal was independently related to early recurrence. Umbas and co-workers (Umbas et al, 1997) reported that all four cases out of 20 patients treated by radical prostatectomy and having aberrant expression of α-catenin recurred, while those tumours with normal expression had no recurrence within 40 months follow-up. In another study α-catenin had significant prognostic value in terms of recurrencefree survival but α-catenin expression was not related to survival (Crundwell et al, 1997) . In the study by Richmond and co-workers (Richmond et al, 1997) α-catenin was an important prognostic factor only in the univariate analysis. Umbas et al (1997) also observed that α-catenin was a predictor of patient outcome in advanced disease and recurrence-free survival in radically treated local tumours. However, they have not described the accuracy of preoperative TNM in comparison to final post-operative pTNM classification. Although the disease progression was associated with abnormal α-catenin expression, the question still remains whether α-catenin is an independent predictor of progression. The data in localized renal cell carcinoma suggest that α-catenin, indeed, seems to have independent prognostic value (Shimazui et al, 1997) .
In conclusion, abnormal α-catenin expression is related to advanced disease stages and malignant cellular features in prostate cancer and the analysis of α-catenin expression may give additional prognostic information in M0 prostate cancer.
